Subscribe To
Betterlife pharma to present betr-001 preclinical data at fens forum in paris, france in july
BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) has announced that an abstract covering the anti-depressant activity of its lead compound 2-bromo-LSD ...
June 21, 2022, 9:31 am
Vertex to present data demonstrating significant benefits of long-term and early treatment with cftr modulators at the european cystic fibrosis conference
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that five scientific abstracts on the company's portfolio ...
June 10, 2022, 11:00 am
4d pharma conference poster underlines safety and potential efficacy of asthma drug candidate
4D pharma PLC (AIM:DDDD, NASDAQ:LBPS) said it will present an update from the phase I/II trial of its putative asthma treatment at an industry confere...
May 17, 2022, 2:29 am
Absolute software corporation's (abst) ceo christy wyatt on q3 2022 results - earnings call transcript
Absolute Software Corporation (NASDAQ:abst ) Q3 2022 Earnings Conference Call May 10, 2022 5:00 PM ET C...
May 10, 2022, 10:57 pm
Verona pharma to present successful tqt analysis demonstrating no clinically relevant effect on cardiac conduction at the american thoracic society 2022
Abstract supports ongoing Phase 3 program and planned NDA submission Abstract supports ongoing Phase 3 program and planned NDA submission...
May 9, 2022, 2:00 am
Context therapeutics announces poster presentation at upcoming 2022 asco annual meeting
Context Therapeutics (NASDAQ:CNTX) Inc has told investors that an abstract on the results of the monotherapy portion of its ongoing Phase 2 trial of l...
May 5, 2022, 10:02 am
Athenex, texas children's cancer center, and the center for cell and gene therapy at baylor college of medicine to present phase 1 clinical data for kur-501, an autologous gd2 car-nkt cell therapy for
BUFFALO, N.Y., May 02, 2022 (GLOBE NEWSWIRE) -- Athenex (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, an...
May 2, 2022, 5:27 pm
Athenex, texas children's cancer center, and the center for cell and gene therapy at baylor college of medicine to present phase 1 clinical data for kur-501, an autologous gd2 car-nkt cell therapy for
BUFFALO, N.Y., May 02, 2022 (GLOBE NEWSWIRE) -- Athenex (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, an...
May 2, 2022, 5:27 pm
Freeline to present at the 25th annual meeting of the american society of gene and cell therapy
Five abstracts accepted with new research and technology insights and data to further enhance AAV-based gene therapy candidates Five abstracts accept...
May 2, 2022, 5:10 pm
Pjsc mechel : mechel announces decision not to report 1q2022 financial and operational results
MOSCOW, RUSSIA / ACCESSWIRE / April 29, 2022 / Mechel PAO (MOEX:MTLR, NYSE:MTL), one of the leading Russian mining and metals companies, decided to te...
April 29, 2022, 6:50 am
Betterlife to present betr-001 preclinical data at canadian association for neuroscience conference
BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) has announced that an abstract from the preclinical data on anti-depressant activity of its lead compou...
April 21, 2022, 10:02 am
Guaranty bancshares, inc.'s (gnty) ceo ty abston on q1 2022 results - earnings call transcript
Guaranty Bancshares, Inc. (NASDAQ:GNTY ) Q1 2022 Earnings Conference Call April 18, 2022 11:00 AM ET Company Participants Ty Abston - Chairman and CEO...
April 18, 2022, 1:56 pm
Todos medical reports case study of patient with long covid who used its dietary supplement tollovid after doctor recommendation
Todos Medical Ltd announced that its majority-owned subsidiary 3CL Pharma, Ltd is reporting a case study from a patient with long COVID who was re...
March 31, 2022, 1:57 pm
Jacobs (j) to offer netabstraction's netaccess & neteclave
Jacobs Engineering Group's (J) partnership with NightDragon to build, co-invest, and market a joint cyber, intelligence and digital ecosystem....
March 30, 2022, 1:33 pm
Genentech to present data across broad and impactful neuroscience portfolio at 2022 aan annual meeting
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced new data for its ap...
March 25, 2022, 2:00 am
Roche to present data across broad and impactful neuroscience portfolio at 2022 aan annual meeting
Basel, 25 March 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new data for its approved and investigational medicines across neurological ...
March 25, 2022, 2:00 am
Personalis to present data demonstrating breadth of next platform for oncology at aacr annual meeting 2022
MENLO PARK, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced it is presenting...
March 23, 2022, 9:01 am
Applied therapeutics to present at the 2022 annual clinical genetics meeting of the american college of molecular genetics and genomics
NEW YORK, March 16, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeli...
March 16, 2022, 7:30 am
Synaptogenix to present research highlighting potential broad applicability for lead compound bryostatin at the international conference on alzheimer's and parkinson's diseases (ad/pd 2022)
NEW YORK , March 15, 2022 /PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX), an emerging biopharmaceutical company developing regenerative therapeutic...
March 15, 2022, 9:15 am
Cullinan oncology to present data demonstrating breadth and progress of its immuno-oncology portfolio at aacr 2022
Five abstracts selected for poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2022...
March 8, 2022, 5:30 pm